Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $1.67 billion. The enterprise value is $1.27 billion.
| Market Cap | 1.67B |
| Enterprise Value | 1.27B |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 325.83 million shares outstanding. The number of shares has increased by 31.09% in one year.
| Current Share Class | 325.83M |
| Shares Outstanding | 325.83M |
| Shares Change (YoY) | +31.09% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 8.07% |
| Owned by Institutions (%) | 73.23% |
| Float | 232.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 306.53 |
| Forward PS | 539.19 |
| PB Ratio | 4.33 |
| P/TBV Ratio | 4.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 233.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.76, with a Debt / Equity ratio of 0.15.
| Current Ratio | 17.76 |
| Quick Ratio | 17.53 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,646.64 |
Financial Efficiency
Return on equity (ROE) is -47.05% and return on invested capital (ROIC) is -25.44%.
| Return on Equity (ROE) | -47.05% |
| Return on Assets (ROA) | -23.82% |
| Return on Invested Capital (ROIC) | -25.44% |
| Return on Capital Employed (ROCE) | -34.46% |
| Weighted Average Cost of Capital (WACC) | 10.35% |
| Revenue Per Employee | $55,404 |
| Profits Per Employee | -$1.51M |
| Employee Count | 99 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +82.33% in the last 52 weeks. The beta is 1.17, so TSHA's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +82.33% |
| 50-Day Moving Average | 5.78 |
| 200-Day Moving Average | 5.48 |
| Relative Strength Index (RSI) | 38.93 |
| Average Volume (20 Days) | 2,924,613 |
Short Selling Information
The latest short interest is 46.80 million, so 14.36% of the outstanding shares have been sold short.
| Short Interest | 46.80M |
| Short Previous Month | 46.74M |
| Short % of Shares Out | 14.36% |
| Short % of Float | 20.12% |
| Short Ratio (days to cover) | 18.16 |
Income Statement
In the last 12 months, TSHA had revenue of $5.49 million and -$149.63 million in losses. Loss per share was -$0.41.
| Revenue | 5.49M |
| Gross Profit | 5.49M |
| Operating Income | -153.16M |
| Pretax Income | -149.63M |
| Net Income | -149.63M |
| EBITDA | -151.99M |
| EBIT | -153.16M |
| Loss Per Share | -$0.41 |
Balance Sheet
The company has $455.41 million in cash and $56.71 million in debt, with a net cash position of $398.69 million or $1.22 per share.
| Cash & Cash Equivalents | 455.41M |
| Total Debt | 56.71M |
| Net Cash | 398.69M |
| Net Cash Per Share | $1.22 |
| Equity (Book Value) | 387.27M |
| Book Value Per Share | 1.19 |
| Working Capital | 435.46M |
Cash Flow
In the last 12 months, operating cash flow was -$132.19 million and capital expenditures -$381,000, giving a free cash flow of -$132.57 million.
| Operating Cash Flow | -132.19M |
| Capital Expenditures | -381,000 |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | 9.24M |
| Free Cash Flow | -132.57M |
| FCF Per Share | -$0.41 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,792.32% |
| Pretax Margin | -2,728.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -31.09% |
| Shareholder Yield | -31.09% |
| Earnings Yield | -8.90% |
| FCF Yield | -7.89% |
Analyst Forecast
The average price target for TSHA is $13.00, which is 154.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 154.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 149.69% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of 6.81 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.81 |
| Piotroski F-Score | 2 |